Lotus Resources (LOT) Q1 2027 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 TU earnings summary
28 Oct, 2026Executive summary
Kayelekera restarted uranium processing in August after the acid plant recommissioning; production reached 101.8klb U3O8 over 31 operating days, with recovery improving to 69% for the quarter and 80% in September.
The quarter advanced export readiness and strengthened funding, while operational reliability, power supply and acid output remain key to the production ramp-up.
Financial highlights
Kayelekera operating costs were A$43.2M in the September quarter, including A$4.6M of take-or-pay settlements; cash expenditure also included payments of accrued June-quarter expenses.
Cash and cash equivalents were A$57.4M at 30 September, versus A$30.1M at 30 June; this excludes US$10.0M restricted as environmental bond collateral.
Appendix 5B reported net operating cash outflow of A$45.2M, investing outflow of A$13.6M and financing inflow of A$85.1M for the quarter.
Outlook and guidance
Acid plant optimisation targets increased output towards nameplate capacity in Q1 2027; grid energisation remains targeted for early CY2027.
Inaugural shipment of four containers containing approximately 145klb U3O8 is scheduled for November, following receipt of final Namibian transport authorisation.
Cash receipts from uranium sales are expected to commence in the upcoming quarter, subject to remaining permitting and export requirements.
Latest events from Lotus Resources
- Operational setbacks at Kayelekera led to a $100M loss, prompting major funding and restructuring.LOT
H2 2026 - Uranium output surged, but acid supply disruptions paused production; major funding secured.LOT
Q4 2026 TU - Operational reset and funding secure Kayelekera's path to steady uranium production and growth.LOT
Investor presentation - Ramp-up advances with strong safety and cash, targeting first uranium shipment and steady-state soon.LOT
Q3 2026 TU - First uranium production achieved at Kayelekera, with strong financing and future cash flow outlook.LOT
H2 2025 - Net assets surged to $127.4M after Letlhakane acquisition and $30M capital raise, despite a $24.5M loss.LOT
H2 2024 - First yellowcake produced at Kayelekera, ramp-up funded by strong capital raises and financing.LOT
H1 2026 - Kayelekera achieved first uranium production in 2025, targeting 2.4Mlbpa steady-state in 2026.LOT
Investor presentation - A$76M equity raise supports Kayelekera ramp-up and Letlhakane development amid strong uranium demand.LOT
Investor presentation